Patient Harm Linked to AI in FDA-Approved Medical Devices
The integration of artificial intelligence (AI) into medical equipment by manufacturers is leading to a concerning rise in device malfunctions and patient injuries. This trend highlights the complex challenges of regulating rapidly evolving technology in healthcare. Since AI was added to the TruDi navigation system by Acclarent, a Johnson & Johnson subsidiary, reports of problems with the device have surged dramatically. FDA data shows that prior to the AI integration, there were seven malfunction reports and one injury. Following its implementation, unconfirmed reports have skyrocketed to at least 100.
Specific Device Failures and Injuries
In 2021, Acclarent incorporated AI into its device for treating chronic sinusitis. From late 2021 through November 2025, at least ten people were injured in connection with the TruDi system. The reported injuries are severe and include:
- Cerebrospinal fluid leaking from the nose
- A puncture at the base of the skull
- Two strokes resulting from damage to a major artery
Two of the stroke victims have already filed lawsuits in Texas.
The TruDi system is not an isolated case. The FDA has recorded that 60 AI-powered medical devices have been associated with 182 product recalls. Alarmingly, 43% of these recalls occurred less than a year after the devices received market authorization. Other problematic devices include a cardiac monitor that failed to detect dangerous arrhythmias and an ultrasound machine that misidentified parts of a fetus's body.
Representatives from Integra LifeSciences, which acquired Acclarent in 2024, state they "merely indicate that the TruDi system was used during a surgery where an adverse event occurred."
They further assert that "there is no reliable evidence to suggest any causal link between the TruDi navigation system, the artificial intelligence technology, and any alleged injuries." While technological advancement in medicine offers significant benefits, it also carries inherent risks, demanding rigorous oversight and evaluation of how novel technologies impact patient safety.
The adoption of AI in medical devices opens new frontiers for improving treatment, but it simultaneously introduces potential threats to patient well-being. The increasing number of injuries and malfunctions underscores the urgent need for more stringent oversight from regulators like the FDA. Comprehensive research and analysis of new technologies' effects on patients must become a priority for equipment manufacturers to minimize risks and ensure effective care.